Hadassah

Hadassah Collaborates with Columbia University to Identify Treatment for Alopecia

Friday, Jun 5 2015

Working in collaboration with Columbia University, a team of Hadassah Medical Organization physicians have discovered that an arthritis medication may be the solution to baldness caused by alopecia.

The researchers have found that Baricitinib, a medicine in development for treatment of rheumatoid arthritis, may prove effective for severe Alopecia Areata (AA), a common autoimmune disease which causes sudden or gradual hair loss. "Despite its high prevalence," the team reports, "there are no Food and Drug Administration-approved treatments for AA."

The team, including Hadassah Dermatologist Dr. Yuval Ramot, Prof. Abraham Zlotogorski, Director of Hadassah Hospital Ein Kerem's Department of Dermatology and its Hair Loss Clinic, and Prof. Yackov Berkun of Hadassah Hospital Mount Scopus' Pediatric Unit, has found the medicine to be effective in both animals and humans.

"This discovery opens a variety of options for future treatment of AA," notes Dr. Ramot. "That said, extensive clinical trials are still needed in order to fully confirm the findings, before marketing these new medications for treatment of AA."

The research team hopes to begin such clinical trials in the near future. The present study is highlighted in the April 2015 issue of EBioMedicine.

Comments

From: Marjorie on June 6, 2015
I believe I would be a candidate for these clinical trials. Please contact me.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Nov 14 2017

Abraham and Sarah — and a Modern-Day Miracle Baby

They're not quite Matriarch Sarah and Patriarch Abraham, who were 90 and 100, respectively, when their son, Isaac, was born. This couple--she’s 48 and he is 62--are parents of a baby boy, thanks to a hand from heaven and the team at Hadassah Hospital Mount Scopus.

READ MORE ›
alt_text

Thursday, Nov 9 2017

New NICU at Hadassah: First of Its Kind in Israel

Tiny patients with big problems are now being treated in the new Neonatal Intensive Care Unit (NICU) at Hadassah Hospital Ein Kerem—the first of its kind in Israel.

READ MORE ›
alt_text

Monday, Oct 30 2017

Hadassah Hospital Metrics on the Rise

HMO By The Numbers

READ MORE ›
alt_text

Tuesday, Oct 24 2017

Hadassah Doctor Brings New Hope to Cystic Fibrosis Patients

Twenty five years ago, Dr. Batsheva Kerem and Dr. Eitan Kerem made a significant contribution to the scientific world’s understanding of genetic mutations and cystic fibrosis.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More